<DOC>
	<DOCNO>NCT01142596</DOCNO>
	<brief_summary>This multi-site , randomized fixed-flexible dose long-term study asenapine participant schizophrenia . The first six week study double-blind remainder study open label . Participants study consist participant complete precede short-term study ( P06124 [ NCT01098110 ] ) , meet inclusion criterion wish continue receive study drug , investigator deem eligible study participation . Participants placebo twice daily ( BID ) core trial P06124 get placebo first 2 week 5 mg asenapine BID next 4 week double blind treatment , re-randomized week 6 asenapine 5 mg BID asenapine 10 mg BID . Participants asenapine 5 mg BID core trial P06124 re-randomized Week 6 asenapine 5 mg BID asenapine 10 mg BID . Participants asenapine 10 mg BID core trial P06124 re-randomized Week 6 asenapine 5 mg BID asenapine 10 mg BID . After re-randomization , drug administer open-label 46 week . During period dose flexible adjusted use dose option 5 10 mg BID efficacy tolerability .</brief_summary>
	<brief_title>Long-term Extension Trial Asenapine Subjects With Schizophrenia ( Study P06125 )</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Asenapine</mesh_term>
	<criteria>Participant complete 42day drug administration precede shortterm study ( Protocol P06124 ) , exhibit efficacy ( CGII completion precede shortterm study markedly improve , moderately improve , slightly improve ) , significant safety problem , judge appropriate study participation investigator . Male female participant . Women childbearing potential ( i.e. , surgically sterile post menopausal least 1 year ) must use medically acceptable birth control . Medically acceptable birth control include condom ( male female ) without spermicidal agent , diaphragm cervical cap spermicide , medically prescribe IUD , insert coppercontaining IUD , hormonereleasing IUD , systemic hormonal contraceptive , surgical sterilization ( eg , hysterectomy tubal ligation ) . Male participant must agree use condom participation study . Participant must explain nature study investigator , able provide write consent prior conduct tests/observation clinical study . A participant must clinically significant abnormal laboratory , vital sign , physical examination , electrocardiogram ( ECG ) finding , investigator 's opinion , preclude participant 's participation study A participant must positive pregnancy test planning become pregnant term study ; A participant must receive antipsychotic , antidepressant , mood stabilizer , antiepileptic , monoamine oxidase inhibitor , St. John 's Wort , antiemetic dopamine antagonist , traditional herbal medication psychiatric symptom baseline ; A participant must risk harm others , investigator 's opinion ; A participant must determine unsuitable investigator .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>